MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

"Triple Helix Innovation Platform for Academia, Industry and Government"

Who's Among Us & From Where?

.... More than 1000 International Members ... From over 30 Countries

Brought to you by MedForeSight

 


The MedForeSight Home Page
MedForeSight Services
Web 2.0 & Content Strategy
Technology Trends & Insights
Growth Strategy & Partnership Planning
Proposal Development
Peer Review
Financial Analysis & Valuation
Funding Mechanisms
Program Management
Regulatory Compliance
Exit Strategies
Global Brand Strategy

 

 

MedTechIQ ...

Accelerating the “Lab to Market” translation of medical technology with the power of the 3Cs of "Content, Community & Collaboration".

MedTech I.Q. makes everything available and helps you find it by crawling hundreds of sources of medical technology daily and then delivering actionable intelligence which allows you to discover, manage and share information with an international community of subject matter experts.   

Publishers: MedForeSight, LLC, click here for homepage.

MedTech-IQ ... At a Glance

  • Add Photos
  • View All

Latest Activity

Adam Fleming posted an event
Thumbnail

21 CFR Part 11 - Compliance for Electronic Records and Signatures at Online

June 26, 2019 from 10am to 11:30am
Overview: This Webinar will explain what 21 CFR Part 11 is, why it is important to FDA regulated companies and how conformance to Part 11 differs from just having good IT security. Procedures for controlling electronic signatures and electronic records as described in the FDA Guidance will be explained.FDA regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being compromised with possible resulting harm to the patient. FDA has set up regulations that address both data security and patient safety. We will show how 21 CFR part 11 considers both. The confusion over the original FDA regulation and its subsequent "selective enforcement" will be explained. FDA requirements for 21CFR Part 11 validation will be explained. the requirements are composed of technical and procedural aspects. open, closed and hybrid (paper and electronic) systems will be explained. Why…See More
yesterday
Joseph Wilcox posted events
Jun 20
Roger Steven posted events
Jun 18
Carl K. Long is now a member of MedTech I.Q.
Jun 8
 
 
 

© 2019   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service